Statistical Problems

Overview

Journal BMJ

Specialty General Medicine

Date 1994 Apr 16

PMID 8167517

Citations 3

Authors

G Davey Smith

M Egger

Affiliations

Soon will be listed here.

Citing Articles

Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Pickin D, McCabe C, Ramsay L, Payne N, Haq I, Yeo W Heart. 1999; 82(3):325-32.

PMID: 10455083 PMC: 1729169. DOI: 10.1136/hrt.82.3.325.

The importance of diet and physical activity in the treatment of conditions managed in general practice.

Little P, Margetts B Br J Gen Pract. 1996; 46(404):187-92.

PMID: 8731628 PMC: 1239582.

Inflation in epidemiology: "the proof and measurement of association between two things" revisited.

Smith G, Phillips A BMJ. 1996; 312(7047):1659-61.

PMID: 8664725 PMC: 2351357. DOI: 10.1136/bmj.312.7047.1659.

References

Hunninghake D, Stein E, Dujovne C, Harris W, Feldman E, Miller V . The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993; 328(17):1213-9. DOI: 10.1056/NEJM199304293281701. View

Law M, Wald N, Thompson S . By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. BMJ. 1994; 308(6925):367-72. PMC: 2539460. DOI: 10.1136/bmj.308.6925.367. View

Law M, Wald N, Wu T, Hackshaw A, Bailey A . Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 1994; 308(6925):363-6. PMC: 2539480. DOI: 10.1136/bmj.308.6925.363. View

FRICK M, ELO O, Haapa K, Heinonen O, Heinsalmi P, Helo P . Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987; 317(20):1237-45. DOI: 10.1056/NEJM198711123172001. View

Davis C, Rifkind B, Brenner H, Gordon D . A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study. JAMA. 1990; 264(23):3044-6. View

Ramsay L, Yeo W, Jackson P . Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991; 303(6808):953-7. PMC: 1671346. DOI: 10.1136/bmj.303.6808.953. View

Smith G, Shipley M, Marmot M, Rose G . Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA. 1992; 267(1):70-6. View

Witztum J, Steinberg D . Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991; 88(6):1785-92. PMC: 295745. DOI: 10.1172/JCI115499. View

Hulley S, Walsh J, Newman T . Health policy on blood cholesterol. Time to change directions. Circulation. 1992; 86(3):1026-9. DOI: 10.1161/01.cir.86.3.1026. View

10.

Assmann G, Schulte H . Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. Am J Cardiol. 1992; 70(7):733-7. DOI: 10.1016/0002-9149(92)90550-i. View

11.

Giles W, Anda R, Jones D, Serdula M, Merritt R, DeStefano F . Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA. 1993; 269(9):1133-8. View

12.

Law M, Thompson S, Wald N . Assessing possible hazards of reducing serum cholesterol. BMJ. 1994; 308(6925):373-9. PMC: 2539477. DOI: 10.1136/bmj.308.6925.373. View

13.

Smith G, Song F, Sheldon T . Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993; 306(6889):1367-73. PMC: 1677836. DOI: 10.1136/bmj.306.6889.1367. View

14.

Shestov D, Deev A, KLIMOV A, Davis C, Tyroler H . Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study. Circulation. 1993; 88(3):846-53. DOI: 10.1161/01.cir.88.3.846. View

15.

Stamler J, STAMLER R, Brown W, Gotto A, Greenland P, Grundy S . Serum cholesterol. Doing the right thing. Circulation. 1993; 88(4 Pt 1):1954-60. DOI: 10.1161/01.cir.88.4.1954. View

16.

Phillips A, Smith G . The design of prospective epidemiological studies: more subjects or better measurements?. J Clin Epidemiol. 1993; 46(10):1203-11. DOI: 10.1016/0895-4356(93)90120-p. View

17.

Bass K, Newschaffer C, Klag M, Bush T . Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993; 153(19):2209-16. View

18.

Smith G . Blood cholesterol and non-coronary mortality. Coron Artery Dis. 1993; 4(10):860-6. DOI: 10.1097/00019501-199310000-00004. View

19.

Manolio T, PEARSON T, Wenger N, Barrett-Connor E, Payne G, HARLAN W . Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 1992; 2(1-2):161-76. DOI: 10.1016/1047-2797(92)90051-q. View

20.

Smith G, Egger M . Who benefits from medical interventions?. BMJ. 1994; 308(6921):72-4. PMC: 2539180. DOI: 10.1136/bmj.308.6921.72. View